Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity and Capitalization (Details)

v3.21.2
Stockholders' Equity and Capitalization (Details) - USD ($)
 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Feb. 05, 2021
Dec. 31, 2020
Equity [Line Items]        
Common stock, shares authorized (in shares) 5,000,000,000   5,000,000,000 500,000,000
Preferred stock, shares authorized (in shares) 50,000,000   50,000,000 20,000,000
Proceeds from common stock warrant exercises $ 5,730,000 $ 0    
Pre-funded Warrants        
Equity [Line Items]        
Number of warrants exercised (in shares) 11,800,000      
Intrinsic value of warrant exercises $ 460,200      
Warrant exercise (in shares) 11,800,000      
Proceeds from common stock warrant exercises $ 11,800      
2020 Common Stock Warrants        
Equity [Line Items]        
Number of warrants exercised (in shares) 95,500,001      
Intrinsic value of warrant exercises $ 6,859,967      
Warrant exercise (in shares) 95,500,001      
Proceeds from common stock warrant exercises $ 5,730,000